You are required to be logged in to access the full website
Click here if you have forgotten your username or password
Therapy Areas
12 December 2018 - BiomX Ltd, a microbiome company developing customised phage therapies, announced yesterday that it has named Dr Sailaja Puttagunta, MD, as its new chief medical officer.Dr Puttagunta will manage the company's clinical developm...
12 December 2018 - The United States Food and Drug Administration (FDA) has approved the New Drug Application for Australia-based Mayne Pharma Group Limited's (ASX: MYX) Tolsura (SUBA-itraconazole) 65mg capsules, it was reported yesterday.The pr...
12 December 2018 - United Kingdom-based e-therapeutics has signed a research collaboration with Novo Nordisk, a Danish drug manufacturer, intended to discover biological mechanisms and therapies to treat type-2 diabetes, it was reported yesterday.Acc...
12 December 2018 - Biopharmaceutical company Hansa Medical AB (STO:HMED) announced on Tuesday that at the extraordinary general meeting, held on 11 December 2018, it was resolved to change Hansa Medical's company name to Hansa Biopharma AB, in a...
11 December 2018 - - Patient dosing has begun in a Phase I clinical study of BAT4306F in relapsed/refractory CD20-positive B-cell non-Hodgkin's lymphoma patients, Chinese clinical-stage pharmaceutical company Bio-Thera Solutions said.
11 December 2018 - - US-based diagnostics company Biotheranostics, Inc. has presented new data at the San Antonio Breast Cancer Symposium evaluating the impact of the Breast Cancer Index in early stage hormone receptor positive breast cancer patients...
11 December 2018 - - US-based gene control medicines developer Syros Pharmaceuticals (NASDAQ: SYRS) has released new preclinical data on SY-1365, its first-in-class selective cyclin-dependent kinase 7 inhibitor, showing that it inhibits tumor cell gr...